Search PubMed⌕ Search

PubMed · 9068885

Epilepsy surgery.

Abstract

Surgical therapy of epilepsy, although still underutilized, is presently well accepted and performed world-wide with increasing frequency. In the last decade the following changes have been noticed: non-invasive pre-surgical evaluation is increasingly carried out in close collaboration with referring centres so that often no (or only a very short) hospitalization is necessary in highly specialized epilepsy centres for this purpose. Stereoelectro-encephalography (SEEG) is used less often in invasive evaluation while the subdural strip and grid electrode-techniques are used more often. There is a general trend for a more flexible and collaborative multidisciplinary and multi-method approach utilizing the whole spectrum of modern diagnostic facilities in a more patient-oriented and therefore more cost-effective way. The main objective of the pre-surgical evaluation is to determine the onset area of the patient's spontaneous habitual seizures. The primary epileptogenic zone is not necessarily synonymous with the so-called lesional zone, although in the great majority of patients they are related. In a small percentage of candidates for epilepsy surgery additional special examinations are necessary to prevent and/or predict the degree of post-operative deficits. At present selective Amytal tests are often used but these invasive procedures might be replaced in the future by functional PET and functional MR studies. Surgery in patients with epilepsy can be categorized into: (i) lesion-oriented surgery (lesionectomy sensu stricto), (ii) epilepsy-oriented lesional surgery, (iii) surgery for epilepsy sensu stricto. Surgery is performed with a 'curative (= causal)' or a 'palliative' intention. Furthermore surgery can be categorized into standardized epilepsy surgery (such as anterior temporal lobe resection, selective amygdalohippeocampectomy, anterior callosotomy); and individually tailored surgical interventions. It is obvious that also so-called standardized operations are tailored to some degree, usually based on pre-operative findings as well as on intraoperative corticography and/or other intra-operative neurophysiological tests (functional mapping). Individually tailored operations comprise smaller topectomies and larger resections. Surgery for temporal lobe epilepsy still prevails. For mesial temporal lobe epilepsy more selective operations, such as the selective amygdalohippocampectomy, are increasingly performed. Today the majority of patients suffering from this syndrome can be evaluated non-invasively (or 'semi-invasively' with the foramen ovale electrode technique) in combination with MRI (including volumetry of the hippocampus) and PET or SPECT. In general one has the impression that extratemporal resections without a lesion are performed less often. But, if a morphological abnormality is present, pre-surgical evaluation (using grids), and surgery making use of 'functional mapping' are increasingly offered from more and more centres. Anterior callosal sections and functional hemispherectomies have also witnessed a renaissance. The most important standardized operations are reviewed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H G Wieser. 1996. Epilepsy surgery.. https://pubmed.ncbi.nlm.nih.gov/9068885/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Postsynaptic targets of somatostatin-containing interneurons in the rat basolateral amygdala.

The basolateral amygdala contains several subpopulations of inhibitory interneurons that can be distinguished on the basis of their content of calcium-binding proteins or peptides. Although previous studies have shown that interneuronal subpopulations containing parvalbumin (PV) or vasoactive intestinal peptide (VIP) innervate distinct postsynaptic domains of pyramidal cells as well as other interneurons, very little is known about the synaptic outputs of the interneuronal subpopulation that expresses somatostatin (SOM). The present study utilized dual-labeling immunocytochemical techniques at the light and electron microscopic levels to analyze the innervation of pyramidal cells, PV+ interneurons, and VIP+ interneurons in the anterior basolateral amygdalar nucleus (BLa) by SOM+ axon terminals. Pyramidal cell somata and dendrites were selectively labeled with antibodies to calcium/calmodulin-dependent protein kinase II (CaMK); previous studies have shown that the vast majority of dendritic spines, whether CAMK+ or not, arise from pyramidal cells. Almost all SOM+ axon terminals formed symmetrical synapses. The main postsynaptic targets of SOM+ terminals were small-caliber CaMK+ dendrites and dendritic spines, some of which were CaMK+. These SOM+ synapses with dendrites were often in close proximity to asymmetrical (excitatory) synapses to these same structures formed by unlabeled terminals. Few SOM+ terminals formed synapses with CaMK+ pyramidal cell somata or large-caliber (proximal) dendrites. Likewise, only 15% of SOM+ terminals formed synapses with PV+, VIP+, or SOM+ interneurons. These findings suggest that inhibitory inputs from SOM+ interneurons may interact with excitatory inputs to pyramidal cell distal dendrites in the BLa. These interactions might affect synaptic plasticity related to emotional learning.

Amygdala↗

Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze.

Serotonin (5-HT) can either increase or decrease anxiety-like behaviour in animals, actions that depend upon neuroanatomical site of action and 5-HT receptor subtype. Although systemic studies with 5-HT(2) receptor agonists and antagonists suggest a facilitatory role for this receptor subtype in anxiety, somewhat inconsistent results have been obtained when such compounds have been directly applied to limbic targets such as the hippocampus and amygdala. The present study investigated the effects of the 5-HT(2B/2C) receptor agonist mCPP bilaterally microinjected into the dorsal hippocampus (DH: 0, 0.3, 1.0 or 3.0nmol/0.2microl), the ventral hippocampus (VH: 0, 0.3, 1.0 or 3.0nmol/0.2microl) or the amygdaloid complex (0, 0.15, 0.5, 1.0 or 3.0nmol/0.1microl) in mice exposed to the elevated plus-maze (EPM). Test sessions were videotaped and subsequently scored for conventional indices of anxiety (percentage of open arm entries and percentage of open arm time) and locomotor activity (closed arm entries). Results showed that mCPP microinfusions into the DH or VH failed to affect any behavioural measure in the EPM. However, when injected into the amygdaloid complex, the dose of 1.0nmol of this 5HT(2B/2C) receptor agonist increased behavioural indices of anxiety without significantly altering general activity levels. This anxiogenic-like effect of mCPP was selectively and completely blocked by local injection of a behaviourally-inactive dose of SDZ SER-082 (10nmol/0.1microl), a preferential 5-HT(2C) receptor antagonist. These data suggest that 5HT(2C) receptors located within the amygdaloid complex (but not the dorsal or ventral hippocampus) play a facilitatory role in plus-maze anxiety in mice.

Amygdala↗

Distribution of NMDA and AMPA receptor subunits at thalamo-amygdaloid dendritic spines.

Synapses onto dendritic spines in the lateral amygdala formed by afferents from the auditory thalamus represent a site of plasticity in Pavlovian fear conditioning. Previous work has demonstrated that thalamic afferents synapse onto LA spines expressing glutamate receptor (GluR) subunits, but the GluR subunit distribution at the synapse and within the cytoplasm has not been characterized. Therefore, we performed a quantitative analysis for alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor subunits GluR2 and GluR3 and N-methyl-D-aspartate (NMDA) receptor subunits NR1 and NR2B by combining anterograde labeling of thalamo-amygdaloid afferents with postembedding immunoelectron microscopy for the GluRs in adult rats. A high percentage of thalamo-amygdaloid spines was immunoreactive for GluR2 (80%), GluR3 (83%), and NR1 (83%), while a smaller proportion of spines expressed NR2B (59%). To compare across the various subunits, the cytoplasmic to synaptic ratios of GluRs were measured within thalamo-amygdaloid spines. Analyses revealed that the cytoplasmic pool of GluR2 receptors was twice as large compared to the GluR3, NR1, and NR2B subunits. Our data also show that in the adult brain, the NR2B subunit is expressed in the majority of in thalamo-amygdaloid spines and that within these spines, the various GluRs are differentially distributed between synaptic and non-synaptic sites. The prevalence of the NR2B subunit in thalamo-amygdaloid spines provides morphological evidence supporting its role in the fear conditioning circuit while the differential distribution of the GluR subtypes may reflect distinct roles for their involvement in this circuitry and synaptic plasticity.

Amygdala↗